NATCO PHARMA
|
NATCO PHARMA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹36 Cr | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹37 Cr |
| Equity - Authorised | ₹45 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
| Equity - Issued | ₹36 Cr | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹37 Cr |
| Equity Paid Up | ₹36 Cr | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹37 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | - | - | - | - | ₹3.40 Cr |
| Total Reserves | ₹9,185 Cr | ₹7,571 Cr | ₹5,817 Cr | ₹4,837 Cr | ₹4,224 Cr |
| Securities Premium | ₹1,202 Cr | ₹1,202 Cr | ₹1,202 Cr | ₹1,407 Cr | ₹1,408 Cr |
| Capital Reserves | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹52 Cr |
| Profit & Loss Account Balance | ₹7,589 Cr | ₹6,247 Cr | ₹4,466 Cr | ₹3,292 Cr | ₹2,667 Cr |
| General Reserves | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
| Other Reserves | ₹284 Cr | ₹12 Cr | ₹39 Cr | ₹27 Cr | ₹38 Cr |
| Reserve excluding Revaluation Reserve | ₹9,185 Cr | ₹7,571 Cr | ₹5,817 Cr | ₹4,837 Cr | ₹4,224 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹9,221 Cr | ₹7,607 Cr | ₹5,853 Cr | ₹4,874 Cr | ₹4,264 Cr |
| Minority Interest | - | ₹5.30 Cr | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹100 Cr | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹100 Cr | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-232 Cr | ₹-50 Cr | ₹-19 Cr | ₹12 Cr | ₹30 Cr |
| Deferred Tax Assets | ₹417 Cr | ₹296 Cr | ₹228 Cr | ₹196 Cr | ₹128 Cr |
| Deferred Tax Liability | ₹185 Cr | ₹246 Cr | ₹209 Cr | ₹208 Cr | ₹158 Cr |
| Other Long Term Liabilities | ₹9.70 Cr | ₹9.20 Cr | ₹9.30 Cr | ₹2.80 Cr | ₹9.30 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹62 Cr | ₹66 Cr | ₹71 Cr | ₹85 Cr | ₹96 Cr |
| Total Non-Current Liabilities | ₹-61 Cr | ₹25 Cr | ₹61 Cr | ₹101 Cr | ₹135 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹409 Cr | ₹275 Cr | ₹236 Cr | ₹264 Cr | ₹162 Cr |
| Sundry Creditors | ₹409 Cr | ₹275 Cr | ₹236 Cr | ₹264 Cr | ₹162 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹615 Cr | ₹239 Cr | ₹239 Cr | ₹227 Cr | ₹127 Cr |
| Bank Overdraft / Short term credit | - | - | ₹15 Cr | ₹9.40 Cr | ₹17 Cr |
| Advances received from customers | ₹88 Cr | ₹83 Cr | ₹85 Cr | ₹86 Cr | ₹3.00 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹527 Cr | ₹156 Cr | ₹139 Cr | ₹132 Cr | ₹107 Cr |
| Short Term Borrowings | ₹306 Cr | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr |
| Secured ST Loans repayable on Demands | ₹173 Cr | ₹182 Cr | ₹167 Cr | ₹75 Cr | ₹289 Cr |
| Working Capital Loans- Sec | ₹173 Cr | ₹182 Cr | ₹167 Cr | ₹75 Cr | ₹289 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-39 Cr | ₹-91 Cr | ₹29 Cr | ₹15 Cr | ₹-174 Cr |
| Short Term Provisions | ₹351 Cr | ₹157 Cr | ₹135 Cr | ₹27 Cr | ₹18 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹0.50 Cr | ₹79 Cr | ₹32 Cr | ₹10 Cr | ₹0.90 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹350 Cr | ₹78 Cr | ₹103 Cr | ₹17 Cr | ₹17 Cr |
| Total Current Liabilities | ₹1,681 Cr | ₹944 Cr | ₹973 Cr | ₹683 Cr | ₹710 Cr |
| Total Liabilities | ₹10,841 Cr | ₹8,581 Cr | ₹6,887 Cr | ₹5,657 Cr | ₹5,109 Cr |
| ASSETS | |||||
| Gross Block | ₹4,256 Cr | ₹4,015 Cr | ₹3,603 Cr | ₹3,375 Cr | ₹3,127 Cr |
| Less: Accumulated Depreciation | ₹1,403 Cr | ₹1,267 Cr | ₹1,112 Cr | ₹948 Cr | ₹815 Cr |
| Less: Impairment of Assets | ₹50 Cr | ₹50 Cr | - | - | - |
| Net Block | ₹2,803 Cr | ₹2,698 Cr | ₹2,491 Cr | ₹2,427 Cr | ₹2,312 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹294 Cr | ₹225 Cr | ₹137 Cr | ₹64 Cr | ₹130 Cr |
| Non Current Investments | ₹2,549 Cr | ₹153 Cr | ₹96 Cr | ₹87 Cr | ₹104 Cr |
| Long Term Investment | ₹2,549 Cr | ₹153 Cr | ₹96 Cr | ₹87 Cr | ₹104 Cr |
| Quoted | - | - | - | - | ₹40 Cr |
| Unquoted | ₹2,549 Cr | ₹153 Cr | ₹96 Cr | ₹87 Cr | ₹64 Cr |
| Long Term Loans & Advances | ₹101 Cr | ₹74 Cr | ₹113 Cr | ₹78 Cr | ₹72 Cr |
| Other Non Current Assets | ₹43 Cr | ₹161 Cr | ₹27 Cr | ₹0.30 Cr | ₹4.70 Cr |
| Total Non-Current Assets | ₹5,789 Cr | ₹3,311 Cr | ₹2,863 Cr | ₹2,657 Cr | ₹2,622 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹578 Cr | ₹321 Cr | ₹444 Cr | ₹305 Cr | ₹204 Cr |
| Quoted | ₹450 Cr | ₹217 Cr | ₹144 Cr | ₹101 Cr | ₹82 Cr |
| Unquoted | ₹128 Cr | ₹104 Cr | ₹300 Cr | ₹204 Cr | ₹122 Cr |
| Inventories | ₹909 Cr | ₹766 Cr | ₹701 Cr | ₹743 Cr | ₹762 Cr |
| Raw Materials | ₹274 Cr | ₹234 Cr | ₹204 Cr | ₹222 Cr | ₹245 Cr |
| Work-in Progress | ₹143 Cr | ₹125 Cr | ₹102 Cr | ₹129 Cr | ₹175 Cr |
| Finished Goods | ₹350 Cr | ₹237 Cr | ₹238 Cr | ₹278 Cr | ₹206 Cr |
| Packing Materials | ₹40 Cr | ₹51 Cr | ₹42 Cr | ₹30 Cr | ₹31 Cr |
| Stores  and Spare | ₹78 Cr | ₹96 Cr | ₹78 Cr | ₹74 Cr | ₹97 Cr |
| Other Inventory | ₹24 Cr | ₹23 Cr | ₹36 Cr | ₹9.40 Cr | ₹8.50 Cr |
| Sundry Debtors | ₹881 Cr | ₹1,247 Cr | ₹1,189 Cr | ₹856 Cr | ₹621 Cr |
| Debtors more than Six months | ₹18 Cr | ₹19 Cr | ₹14 Cr | ₹20 Cr | ₹87 Cr |
| Debtors Others | ₹883 Cr | ₹1,247 Cr | ₹1,195 Cr | ₹852 Cr | ₹576 Cr |
| Cash and Bank | ₹1,551 Cr | ₹2,176 Cr | ₹953 Cr | ₹546 Cr | ₹206 Cr |
| Cash in hand | ₹0.30 Cr | ₹0.20 Cr | ₹0.30 Cr | ₹0.30 Cr | ₹0.40 Cr |
| Balances at Bank | ₹1,551 Cr | ₹2,176 Cr | ₹953 Cr | ₹546 Cr | ₹206 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹102 Cr | ₹135 Cr | ₹100 Cr | ₹64 Cr | ₹88 Cr |
| Interest accrued on Investments | ₹73 Cr | ₹100 Cr | ₹66 Cr | ₹29 Cr | ₹25 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹22 Cr | ₹31 Cr | ₹29 Cr | ₹28 Cr | ₹33 Cr |
| Other current_assets | ₹7.50 Cr | ₹4.20 Cr | ₹4.20 Cr | ₹7.60 Cr | ₹30 Cr |
| Short Term Loans and Advances | ₹1,031 Cr | ₹626 Cr | ₹638 Cr | ₹486 Cr | ₹606 Cr |
| Advances recoverable in cash or in kind | ₹106 Cr | ₹101 Cr | ₹111 Cr | ₹66 Cr | ₹100 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹925 Cr | ₹525 Cr | ₹528 Cr | ₹420 Cr | ₹506 Cr |
| Total Current Assets | ₹5,052 Cr | ₹5,270 Cr | ₹4,024 Cr | ₹3,000 Cr | ₹2,487 Cr |
| Net Current Assets (Including Current Investments) | ₹3,371 Cr | ₹4,327 Cr | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹10,841 Cr | ₹8,581 Cr | ₹6,887 Cr | ₹5,657 Cr | ₹5,109 Cr |
| Contingent Liabilities | ₹3.00 Cr | ₹3.00 Cr | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr |
| Total Debt | ₹706 Cr | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr |
| Book Value | - | 424.97 | 326.99 | 267.06 | 233.44 |
| Adjusted Book Value | 515.15 | 424.97 | 326.99 | 267.06 | 233.44 |
Compare Balance Sheet of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,018.4 Cr | -1.6% | -9.1% | -3.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.6% |
-9.1% |
-3.1% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses